Neurology
Our mission, as the Department of Neurology, is to provide outstanding care for patients with disease affecting the nervous system, advance understanding and treatment of these conditions through research and other scholarly work, and educate the next generation of physicians and scientists in the field.
News
September 1, 2021
NIH Awards $1.4 Million for Sleep and Dementia Research
Principal investigators Tiffany Braley MD, MS and Galit Levi Dunietz PhD, MPH were recently awarded $1.4M in new R01 funding by the National Institute on Aging to study unexplored pathways between obstructive sleep apnea (OSA), OSA treatment, and dementia risk in older women and men. To study these pathways, Braley and Dunietz will utilize
September 1, 2021
NIH Awards $3.3 Million for Research on Cannabinoids in People with Multiple Sclerosis
Principal investigators Tiffany Braley MD, MS (Neurology) and Anna Kratz PhD (Physical Medicine and Rehabilitation) were recently awarded $3.3M in new R01 funding from the National Center for Complimentary and Integrative Health to conduct research on the effects of cannabinoids on sleep and pain in people with MS. This mechanistic trial will
August 23, 2021
Alzheimer’s research center receives $15.3 million in federal funding
The Michigan Alzheimer’s Disease Research Center received continued funding from the National Institutes of Health to continue its work across the state of Michigan for five more years.
More information can be found on their website
August 8, 2021
Parkinson's Disease Strikes More Patients as Treatment Improves
Dr. Roger Albin interviews with Crain's Detroit Business about Parkinson's Disease and its possible relation to viral infections.
Subscription may be required for full access.
July 30, 2021
New Research Highlights Important Pathway for Drug Treatment in Alzheimer’s Disease, Parkinson’s Disease, and Frontotemporal Dementia
Ann Arbor, MI – The work of affiliates of the Michigan Alzheimer’s Disease Research Center captured the attention of the Journal of Biological Chemistry last week for their new findings which could change the trajectory of treatment for key neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, frontotemporal dementia and
